Back to search

Article

Preclinical Assessment of Synergistic Efficacy of MELK and CDKs inhibitors in Adrenocortical Cancer

2022-05-16

Abstract excerpt

<title>Abstract</title> <p>Background Adrenocortical cancer (ACC) is a rare and aggressive cancer with dismal 5-year survival due to a lack of effective treatments. We aimed to identify a new effective combination of drugs and investigated their synergistic efficacy in ACC preclinical models. Methods A quantitative high-throughput drug screening of 4,991 compounds was performed on two ACC cell lines, SW13 and N...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cf015cc5-2e84-51e4-8ebb-84c20f6093ba
DOI
10.21203/rs.3.rs-1631195/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preclinical Assessment of Synergistic Efficacy of MELK and CDKs inhibitors in Adrenocortical CancerDOI 10.21203/rs.3.rs-1631195/v1
Select a neighboring publication to make it the new centre.